Chromophobe renal cell carcinoma - case report

Malignant tumors of the kidney, which the most common is renal cell carcinoma (RCC) is diagnosed in Poland in more than 5,000 patients each year. Most cases of kidney cancer occurs after the age of 55 years. In men, the risk is 2 times higher than in women. Among the various histological subtypes of...

Full description

Saved in:
Bibliographic Details
Published inPolski merkuriusz lekarski Vol. 38; no. 224; p. 100
Main Authors Krawiec, Kamil, Marks, Piotr, Różański, Waldemar, Lipiński, Marek
Format Journal Article
LanguagePolish
Published Poland 01.02.2015
Subjects
Carcinoma, Renal Cell - diagnosis
Carcinoma, Renal Cell - pathology
Carcinoma, Renal Cell - surgery
Carcinoma, Renal Cell - therapy
Humans
Kidney Neoplasms - diagnosis
Kidney Neoplasms - pathology
Kidney Neoplasms - surgery
Kidney Neoplasms - therapy
Lymphatic Metastasis
Male
Middle Aged
Neoplasm Staging
Radiotherapy, Adjuvant
Tomography, X-Ray Computed
hybrid chromophobe cancer
inhibitor
chromophobe renal cell carcinoma
oncocytoma
tyrosine kinase
Online AccessGet more information

Cover

More Information
Summary:Malignant tumors of the kidney, which the most common is renal cell carcinoma (RCC) is diagnosed in Poland in more than 5,000 patients each year. Most cases of kidney cancer occurs after the age of 55 years. In men, the risk is 2 times higher than in women. Among the various histological subtypes of RCC, 5% of cases of chromophobe renal cell carcinoma (chRCC). The 1% is in combination with oncocytoma, creating a hybrid chromophobe renal cell carcinoma. The paper presents a case report of a patient operated on because of a kidney tumor - eosinophilic type of chromophobe cancer. During subsequent care of patients experienced a rare complication of this type of tumor, ie. metastasized to the paraaortic lymph nodes. Another surgery and radiotherapy were later stages of treatment. Discussed in the paper example of a patient with type eosinophilic chRCC indicate the variable nature and mileage as compared with typical of the tumor, thus requiring increased surveillance oncology. This requires a careful approach clinicians at the stage of diagnosis and then treatment and aftercare.
ISSN:1426-9686